Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Malignant Germ Cell Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004017
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Peregrine Pharmaceuticals 60
Not applicableStudy completedNCT00828516
What this trial is testing

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Who this might be right for
Breast CancerHead and Neck CancerLymphedema
East and North Hertfordshire NHS Trust 56
Early research (Phase 1)Study completedNCT02026271
What this trial is testing

Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Oligoastrocytoma
Alaunos Therapeutics 40
Early research (Phase 1)Temporarily pausedNCT04222309
What this trial is testing

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
GliomaGlioma, MalignantGlioblastoma+4 more
Northwell Health 10
Testing effectiveness (Phase 2)Looking for participantsNCT07416188
What this trial is testing

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeRelapsed Cancer+12 more
National Institute of Neurological Disorders and Stroke (NINDS) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT00101166
What this trial is testing

Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 43
Testing effectiveness (Phase 2)Ended earlyNCT01340794
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Who this might be right for
Extra-Adrenal ParagangliomaMetastatic Adrenal Gland PheochromocytomaParaganglioma+1 more
National Cancer Institute (NCI) 7
Very early researchActive Not RecruitingNCT05182905
What this trial is testing

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Who this might be right for
GlioblastomaGliomaGlioblastoma Multiforme+1 more
Nader Sanai 97
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Early research (Phase 1)Study completedNCT02197169
What this trial is testing

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

Who this might be right for
Glioblastoma or Gliosarcoma
DNAtrix, Inc. 37
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Study completedNCT02540161
What this trial is testing

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

Who this might be right for
Malignant Glioma
Annick Desjardins 43
Very early researchStudy completedNCT04937413
What this trial is testing

The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation

Who this might be right for
Malignant GliomaGlioblastoma
Duke University 32
Testing effectiveness (Phase 2)Study completedNCT00704288
What this trial is testing

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Exelixis 222
Not applicableUnknownNCT01588847
What this trial is testing

Anesthesia and Cancer Recurrence im Malignant Melanoma

Who this might be right for
Malignant Melanoma
University Hospital Muenster 230
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Next Page